Skip to main content
. Author manuscript; available in PMC: 2016 Jan 15.
Published in final edited form as: Bioorg Med Chem Lett. 2014 Nov 24;25(2):292–296. doi: 10.1016/j.bmcl.2014.11.047

Figure 2.

Figure 2

Compound 9 shows potent partial agonist activity versus the agonist standard compound 4 in the rNTS2 FLIPR assay.